A new study published in Cancer Cell by researchers at the Broad Institute and the Dana-Farber Cancer Institute focuses on the cancer gene MCL1, according to a Broad press release. MCL1 inhibits apoptosis, and it is one of the most commonly mutated genes in several different kinds of cancer. The study highlights several compounds that repress MCL1.
A Deeper Look
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.